Understanding pharmacology in humans: Phase i and Phase II (Data Generation)

Current Opinion in Pharmacology

Volumn 11, Issue 5, 2011, Pages 557-562

  Merlo Pich, Emilio ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DISUFENTON SODIUM; PAROXETINE; PLACEBO; VESTIPITANT;

ARTICLE; BIOTECHNOLOGY; DEVICE; DRUG INDUSTRY; HUMAN; INFORMATION PROCESSING; INVESTMENT; NANOTECHNOLOGY; ORGANIZATION; OUTCOME ASSESSMENT; PHARMACOLOGY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SOCIAL PHOBIA;

EID: 80053108853     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.06.010     Document Type: Review

References (20)

1. Glossary of Clinical Trial 2011 http://clinicaltrials.gov/ct2/info/ glossary
2. G.Z. Feuerstein, M.M. Zaleska, M. Krams, X. Wang, M. Day, J.L. Rutkowski, S.P. Finklestein, M.N. Pangalos, M. Poole, and G.L. Stiles Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke J Cereb Blood Flow Metab 28 2008 217 219
3. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3 2004 711 716
4. FDA: Innovation or Stagnation. Challenge and Opportunity Report, March 2004.
5. K.I. Kaitin Deconstructing the drug development process: the new face of innovation Clin Pharmacol Therapeut 87 2010 356 361
6. A.D. McCarthy, J.L. Kennedy, and L.T. Middleton Pharmacogenetics in drug development Philos Trans R Soc Lond Ser B: Biol Sci 360 2005 1579 1588
7. J.K. Willmann, N. van Bruggen, L.M. Dinkelborg, and S.S. Gambhir Molecular imaging in drug development Nat Rev Drug Discov 7 2008 591 607 (Pubitemid 351927724)
8. J.A. Bilello The agony and ecstasy of "OMIC" technologies in drug development Curr Mol Med 5 2005 39 52 (Pubitemid 40352873)
9. C.-P. Milne, and K.I. Kaitin Translational Medicine: an engine of change for bringing new technology to community health Sci Transl Med 1 2009 5
10. J. Orloff, F. Douglas, J. Pinheiro, S. Levinson, M. Branson, P. Chaturvedi, E. Ette, P. Gallo, G. Hirsch, and C. Mehta The future of drug development: advancing clinical trial design Nat Rev Drug Discov 8 2009 949 957
11. R. Gomeni Computer assisted drug development (CADD): an emerging technology for risk assessment and decision making during drug development DrugPlus Int 1 2002 25 27
12. M. Kalos An integrative paradigm to impart quality to correlative science J Transl Med 8 2010 26 30
13. E. Merlo-Pich, P. Bettica, and R. Gomeni Bayesian monitoring and bootstrap trial simulation: a new paradigm to implement adaptive trial design for testing antidepressant drugs Open Psychiatry J 3 2009 20 32
14. E. Merlo-Pich, R.C. Alexander, M. Fava, and R. Gomeni A new population enrichment strategy to improve efficiency of placebo-controlled clinical trial in depression Clin Pharmacol Ther 88 2010 634 642
15. T. Furmark, L. Appel, A. Michelgard, K. Wahlstedt, F. Ahs, S. Zancan, E. Jacobsson, K. Flyckt, M. Grohp, and M. Bergstrom Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo Biol Psychiatry 58 2005 132 142 (Pubitemid 41008130)
16. C.-H. Chen, K. Ridler, J. Suckling, S. Williams, C.H.Y. Fu, E. Merlo-Pich, and E. Bullmore Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment Biol Psychiatry 62 2007 407 414 (Pubitemid 47284016)
17. A.P. Carpenter Jr., M.J. Pontecorvo, F.F. Hefti, and D.M. Skovronsky The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience Q J Nucl Med Mol Imaging 53 2009 387 393
18. L. Zhao, W. Jin, D. Rader, C. Packard, and G. Feuerstein A Translational Medicine perspective of the development of torcetrapib Biochem Pharmacol 78 2009 315 325
19. O. Stüve, B.C. Kieseier, B. Hemmer, H.P. Hartung, A. Awad, E.M. Frohman, B.M. Greenberg, M.K. Racke, S.S. Zamvil, and J.T. Phillips Translational research in neurology and neuroscience 2010: multiple sclerosis Arch Neurol 67 2010 1307 1315
20. R.J.Y. Ho, and J.Y. Chien Drug delivery trends in clinical trials and Translational Medicine: updated analysis of clinicaltrials.gov database J Pharm Sci 98 2009 1928 1934